TrialAnnals of hematology2025

Efficacy and safety analysis of China's first 10% IVIg (RonsenGlob) therapy in treating adult ITP.

Lijun Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.